摘要 |
FIELD: medicine, pediatrics, otorhinolaryngology. ^ SUBSTANCE: the present innovation deals with conservative treatment and rehabilitation in children in case of chronic adenoiditis (CA) and in ARVI-suffering ones. It is necessary to isolate the following groups of patients: with CA and purulent exudates, at CA at the background of allergic rhinitis and at CA at the background of intracellular infections. One should carry out conservative therapy along with washing a patient's nasopharynx and differentiated therapy for each group of patients. Therapy includes the intake of mucoregulating preparations, and differentiated therapy for patients with CA and purulent exudates additionally includes local antibacterial therapy with applying Bioparox for 7 d. For patients at CA at the background of allergic rhinitis - application of local antihistamine preparations or mast cells stabilizers. For patients at CA at the background of intracellular infections - two courses of systemic antibacterial therapy with macrolides and Bioparox locally followed by introducing interferonogens or interferon inductors. In about 7-8 d after the onset of therapy course all the patients should undergo 10 seances of quantum therapy with "Rikta" apparatus along with the intake of antioxidants, 4 times annually it is important to conduct rehabilitation with IRS-19, with biopreparation "Narine" endonasally for 10 d, inside - bifidumbacterin per 3 wk by alternating with "Narine". The innovation provides individual curative program for patients with CA of different groups at stable clinic effect of decreased hypertrophy of pharyngeal tonsil up to degree I and restoring microbiocenosis and values of local immunity in nasopharynx. ^ EFFECT: higher efficiency of therapy. ^ 2 tbl |